These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 10096966)

  • 1. Sirolimus (rapamycin) potentiates cyclosporine in prevention of acute lung rejection.
    Longoria J; Roberts RF; Marboe CC; Stouch BC; Starnes VA; Barr ML
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):714-8. PubMed ID: 10096966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine.
    Hausen B; Boeke K; Berry GJ; Segarra IT; Christians U; Morris RE
    J Heart Lung Transplant; 1999 Feb; 18(2):150-9. PubMed ID: 10194039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of acute allograft rejection in nonhuman primate lung transplant recipients: induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressive activity of a regimen using low doses of both microemulsion cyclosporine and 40-O-(2-hydroxyethyl)-rapamycin.
    Hausen B; Gummert J; Berry GJ; Christians U; Serkova N; Ikonen T; Hook L; Legay F; Schuler W; Schreier MH; Morris RE
    Transplantation; 2000 Feb; 69(4):488-96. PubMed ID: 10708100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of acute, ongoing rat lung allograft rejection with the novel immunosuppressant SDZ-RAD.
    Hausen B; Boeke K; Berry GJ; Christians U; Schüler W; Morris RE
    Ann Thorac Surg; 2000 Mar; 69(3):904-9. PubMed ID: 10750781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of low dose cyclosporine A and human interleukin 10 overexpression on acute rejection in rat lung allotransplantation.
    Pierog J; Gazdhar A; Stammberger U; Gugger M; Hyde S; Mathiesen I; Grodzki T; Schmid RA
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1030-5. PubMed ID: 15896613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosol cyclosporine prevents acute allograft rejection in experimental lung transplantation.
    Mitruka SN; Pham SM; Zeevi A; Li S; Cai J; Burckart GJ; Yousem SA; Keenan RJ; Griffith BP
    J Thorac Cardiovasc Surg; 1998 Jan; 115(1):28-36; discussion 36-7. PubMed ID: 9451042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of vincristine with tacrolimus or sirolimus in prevention of acute heart allograft rejection in the rat.
    Jiang W; Jiang J; Xu D; Wang X; Qi S; Ouyang J; Ma A; Vu MD; Bilolo KK; Chen H
    Microsurgery; 2003; 23(2):117-22. PubMed ID: 12740883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of immunosuppressive efficacy by combining the novel leflunomide analog, HMR 279, with microemulsion cyclosporine in a rat lung transplant model.
    Hausen B; Boeke K; Berry GJ; Gummert JF; Christians U; Morris RE
    Transplantation; 1999 Feb; 67(3):354-9. PubMed ID: 10030278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of combination therapy with EPC-K1 and low-dose cyclosporine to pulmonary allograft after rat lung transplantation.
    Udaka T; Misao T; Aoe M; Date H; Andou A; Shimizu N
    J Heart Lung Transplant; 1997 Aug; 16(8):839-45. PubMed ID: 9286776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of CTLA-4Ig and sirolimus on orthotopic lung-allograft survival and histology.
    Ugurlu MM; Griffin MD; Tazelaar HD; McGregor CG
    Transplantation; 2003 Aug; 76(3):489-95. PubMed ID: 12923433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebulized cyclosporine for prevention of acute pulmonary allograft rejection in the rat: pharmacokinetic and histologic study.
    Blot F; Tavakoli R; Sellam S; Epardeau B; Faurisson F; Bernard N; Becquemin MH; Frachon I; Stern M; Pocidalo JJ
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1162-72. PubMed ID: 8719464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sirolimus in combination with low-dose cyclosporine and steroids on acute renal allograft rejection.
    Tsai MK; Chueh SC; Hu RH; Lee PH
    J Formos Med Assoc; 2003 Feb; 102(2):91-6. PubMed ID: 12709737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine elimination in the presence of TOR inhibitors: effects on renal function, acute rejection, and safety.
    Velosa JA; Larson TS; Gloor JM; Stegall MD
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 2):S3-S10. PubMed ID: 11583938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
    Deuse T; Schrepfer S; Pelletier MP; Fischbein MP; Robbins RC; Reichenspurner H
    Transplant Proc; 2007 Mar; 39(2):569-72. PubMed ID: 17362784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability.
    Hausen B; Ikonen T; Briffa N; Berry GJ; Christians U; Robbins RC; Hook L; Serkova N; Benet LZ; Schuler W; Morris RE
    Transplantation; 2000 Jan; 69(1):76-86. PubMed ID: 10653384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation.
    Knight RJ; Kerman RH; Zela S; Podder H; Van Buren CT; Katz S; Kahan BD
    Transplantation; 2003 Apr; 75(8):1301-6. PubMed ID: 12717220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts.
    MacDonald AS;
    Transplantation; 2001 Jan; 71(2):271-80. PubMed ID: 11213073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatment.
    Hausen B; Boeke K; Berry GJ; Segarra I; Benet LZ; Christians U; Morris RE
    Transplantation; 1999 Apr; 67(7):956-62. PubMed ID: 10221478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.